FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3175801675> ?p ?o ?g. }

• W3175801675 endingPage "1869" @default.
• W3175801675 startingPage "1862" @default.
• W3175801675 abstract "Engaging primary care providers (PCPs) in BRCA1/2 testing and results disclosure would increase testing access. The BRCA Founder OutReach (BFOR) study is a prospective study of BRCA1/2 founder mutation screening among individuals of Ashkenazi Jewish descent that sought to involve participants' PCPs in results disclosure. We used quantitative and qualitative methods to evaluate PCPs' perspectives, knowledge, and experience disclosing results in BFOR.Among PCPs nominated by BFOR participants to disclose BRCA1/2 results, we assessed the proportion agreeing to disclose. To examine PCP's perspectives, knowledge, and willingness to disclose results, we surveyed 501 nominated PCPs. To examine PCPs' experiences disclosing results in BFOR, we surveyed 101 PCPs and conducted 10 semi-structured interviews.In the BFOR study overall, PCPs agreed to disclose their patient's results 40.5% of the time. Two hundred thirty-four PCPs (46.7%) responded to the initial survey. Responding PCPs were more likely to agree to disclose patients' results than non-responders (57.3% vs. 28.6%, p<0.001). Among all respondents, most felt very (19.7%) or somewhat (39.1%) qualified to share results. Among PCPs declining to disclose, insufficient knowledge was the most common reason. In multivariable logistic regression, feeling qualified was the only variable significantly associated with agreeing to disclose results (OR 6.53, 95% CI 3.31, 12.88). In post-disclosure surveys (response rate=55%), PCPs reported largely positive experiences. Interview findings suggested that although PCPs valued the study-provided educational materials, they desired better integration of results and decision support into workflows.Barriers exist to incorporating BRCA1/2 testing into primary care. Most PCPs declined to disclose their patients' BFOR results, although survey respondents were motivated and had positive disclosure experiences. PCP training and integrated decision support could be beneficial.ClinicalTrials.gov (NCT03351803), November 24, 2017." @default.
• W3175801675 created "2021-07-05" @default.
• W3175801675 creator A5001757617 @default.
• W3175801675 creator A5004673105 @default.
• W3175801675 creator A5005206482 @default.
• W3175801675 creator A5013641088 @default.
• W3175801675 creator A5029327082 @default.
• W3175801675 creator A5032292766 @default.
• W3175801675 creator A5037525169 @default.
• W3175801675 creator A5040167910 @default.
• W3175801675 creator A5050612979 @default.
• W3175801675 creator A5051532432 @default.
• W3175801675 creator A5052981021 @default.
• W3175801675 creator A5053023370 @default.
• W3175801675 creator A5063299870 @default.
• W3175801675 creator A5063634829 @default.
• W3175801675 creator A5064641228 @default.
• W3175801675 creator A5066655122 @default.
• W3175801675 creator A5072490052 @default.
• W3175801675 creator A5073099896 @default.
• W3175801675 creator A5077144308 @default.
• W3175801675 creator A5080863675 @default.
• W3175801675 creator A5082993956 @default.
• W3175801675 creator A5085950328 @default.
• W3175801675 date "2021-06-25" @default.
• W3175801675 modified "2023-10-16" @default.
• W3175801675 title "Challenges and Opportunities in Engaging Primary Care Providers in BRCA Testing: Results from the BFOR Study" @default.
• W3175801675 cites W1993342975 @default.
• W3175801675 cites W1997863242 @default.
• W3175801675 cites W2026746825 @default.
• W3175801675 cites W2031601414 @default.
• W3175801675 cites W2106226035 @default.
• W3175801675 cites W2145694567 @default.
• W3175801675 cites W2317111255 @default.
• W3175801675 cites W2328105863 @default.
• W3175801675 cites W2565875026 @default.
• W3175801675 cites W2587623479 @default.
• W3175801675 cites W2601206690 @default.
• W3175801675 cites W2627871710 @default.
• W3175801675 cites W2724308665 @default.
• W3175801675 cites W2753122455 @default.
• W3175801675 cites W2758418985 @default.
• W3175801675 cites W2788412160 @default.
• W3175801675 cites W2969248599 @default.
• W3175801675 cites W2969788639 @default.
• W3175801675 cites W3031407742 @default.
• W3175801675 cites W3049065832 @default.
• W3175801675 cites W4252946660 @default.
• W3175801675 doi "https://doi.org/10.1007/s11606-021-06970-8" @default.
• W3175801675 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34173196" @default.
• W3175801675 hasPublicationYear "2021" @default.
• W3175801675 type Work @default.
• W3175801675 sameAs 3175801675 @default.
• W3175801675 citedByCount "2" @default.
• W3175801675 countsByYear W31758016752022 @default.
• W3175801675 crossrefType "journal-article" @default.
• W3175801675 hasAuthorship W3175801675A5001757617 @default.
• W3175801675 hasAuthorship W3175801675A5004673105 @default.
• W3175801675 hasAuthorship W3175801675A5005206482 @default.
• W3175801675 hasAuthorship W3175801675A5013641088 @default.
• W3175801675 hasAuthorship W3175801675A5029327082 @default.
• W3175801675 hasAuthorship W3175801675A5032292766 @default.
• W3175801675 hasAuthorship W3175801675A5037525169 @default.
• W3175801675 hasAuthorship W3175801675A5040167910 @default.
• W3175801675 hasAuthorship W3175801675A5050612979 @default.
• W3175801675 hasAuthorship W3175801675A5051532432 @default.
• W3175801675 hasAuthorship W3175801675A5052981021 @default.
• W3175801675 hasAuthorship W3175801675A5053023370 @default.
• W3175801675 hasAuthorship W3175801675A5063299870 @default.
• W3175801675 hasAuthorship W3175801675A5063634829 @default.
• W3175801675 hasAuthorship W3175801675A5064641228 @default.
• W3175801675 hasAuthorship W3175801675A5066655122 @default.
• W3175801675 hasAuthorship W3175801675A5072490052 @default.
• W3175801675 hasAuthorship W3175801675A5073099896 @default.
• W3175801675 hasAuthorship W3175801675A5077144308 @default.
• W3175801675 hasAuthorship W3175801675A5080863675 @default.
• W3175801675 hasAuthorship W3175801675A5082993956 @default.
• W3175801675 hasAuthorship W3175801675A5085950328 @default.
• W3175801675 hasBestOaLocation W31758016751 @default.
• W3175801675 hasConcept C122980154 @default.
• W3175801675 hasConcept C126322002 @default.
• W3175801675 hasConcept C151956035 @default.
• W3175801675 hasConcept C15744967 @default.
• W3175801675 hasConcept C17744445 @default.
• W3175801675 hasConcept C199539241 @default.
• W3175801675 hasConcept C2781400479 @default.
• W3175801675 hasConcept C2984752397 @default.
• W3175801675 hasConcept C512399662 @default.
• W3175801675 hasConcept C71924100 @default.
• W3175801675 hasConcept C77805123 @default.
• W3175801675 hasConceptScore W3175801675C122980154 @default.
• W3175801675 hasConceptScore W3175801675C126322002 @default.
• W3175801675 hasConceptScore W3175801675C151956035 @default.
• W3175801675 hasConceptScore W3175801675C15744967 @default.
• W3175801675 hasConceptScore W3175801675C17744445 @default.
• W3175801675 hasConceptScore W3175801675C199539241 @default.
• W3175801675 hasConceptScore W3175801675C2781400479 @default.
• W3175801675 hasConceptScore W3175801675C2984752397 @default.

• next